These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24802839)

  • 1. Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Matsuura E; Matsuzaki T; Watanabe O; Kubota R; Izumo S; Takashima H
    PLoS One; 2014; 9(5):e86144. PubMed ID: 24802839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
    Matsuura E; Nozuma S; Tashiro Y; Kubota R; Izumo S; Takashima H
    J Neurol Sci; 2016 Dec; 371():112-116. PubMed ID: 27871430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.
    Souza FDS; Freitas NL; Gomes YCP; Torres RC; Echevarria-Lima J; da Silva-Filho IL; Leite ACCB; de Lima MASD; da Silva MTT; Araújo AQC; Espíndola OM
    Front Immunol; 2021; 12():737941. PubMed ID: 34764955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
    Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
    Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
    Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.
    Gomes YCP; Freitas NL; Souza FS; Sandim V; Pereira DA; Nogueira FCS; Echevarria-Lima J; Leite ACCB; Lima MASD; Silva MTT; Araújo AQC; Vicente ACP; Espíndola OM
    Front Immunol; 2022; 13():949516. PubMed ID: 36052089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
    Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
    Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.
    Matsuzaki T; Nakagawa M; Nagai M; Nobuhara Y; Usuku K; Higuchi I; Takahashi K; Moritoyo T; Arimura K; Izumo S; Akiba S; Osame M
    J Neurovirol; 2000 Dec; 6(6):544-8. PubMed ID: 11175327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
    Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
    Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
    Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
    Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years.
    Matsuzaki T; Nakagawa M; Nagai M; Usuku K; Higuchi I; Arimura K; Kubota H; Izumo S; Akiba S; Osame M
    J Neurovirol; 2001 Jun; 7(3):228-34. PubMed ID: 11517397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Sato T; Coler-Reilly A; Utsunomiya A; Araya N; Yagishita N; Ando H; Yamauchi J; Inoue E; Ueno T; Hasegawa Y; Nishioka K; Nakajima T; Jacobson S; Izumo S; Yamano Y
    PLoS Negl Trop Dis; 2013; 7(10):e2479. PubMed ID: 24130912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.